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Abstract.  Sequence analysis of chromosome IX of 
Saccharomyces cerevisiae revealed an open reading 
frame of 166 residues,  designated  TPM2, having 
64.5 % sequence identity to TPM/,  that encodes the 
major form of tropomyosin in yeast. Purification and 
characterization  of Tpm2p revealed a protein with the 
characteristics of a bona fide tropomyosin; it is present 
in vivo at about one sixth the abundance of Tpmlp. 
Biochemical and sequence analysis indicates that 
Tpm2p spans four actin monomers along a  filament, 
whereas Tpmlp spans five.  Despite its shorter length, 
Tprn2p can compete with Tpmlp for binding to 
F-actin.  Over-expression of Tprn2p  in vivo alters the 
axial budding of haploids to a bipolar pattern, 
and this can be partially suppressed by co-over- 
expression of Tpmlp.  This suggests distinct functions 
for the two tropomyosins, and indicates that the ratio 
between them is important for correct morphogenesis. 
Loss of Tpm2p has no detectable phenotype in other- 
wise wild type cells, but is lethal in combination with 
tpmlA  Over-expression of Tpm2p does not suppress 
the growth or cell surface targeting defects associated 
with tpm/A,  so the two tropomyosins must perform an 
essential function, yet are not functionally interchange- 
able. S.  cerevisiae therefore provides a  simple system 
for the study of two tropomyosins having distinct yet 
overlapping functions. 
T  ROPOMYOSINS are integral  components of the actin- 
based contractile apparatus and actin-based cytoskele- 
ton of muscle and non-muscle cells. All tropomyosins 
are highly ct-helical coiled-coil dimers that bind head-to-tail 
along  the actin  filament  (reviewed by Payne and Rudnick, 
1985).  In striated  muscle, tropomyosin  together with tro- 
ponin  confers  Ca2+-dependent  regulation  of  the  actin- 
myosin interaction  (Ebashi et al., 1972), whereas in smooth 
muscle the association of tropomyosin with caldesmon is be- 
lieved to be involved in thin filament contraction (Bretscher, 
1986). Multiple isoforms of tropomyosins are also found in 
vertebrate non-muscle  cells (Cote,  1983; Lin et al.,  1985; 
Matsumara and Yamashiro-Matsumara,  1985). This diver- 
sity is generated by the expression of different genes as well 
as by alternative  splicing of their transcripts  (Helfman et al., 
1986; reviewed by Breitbart et al.,  1987).  These isoforms 
differ  in  size,  from  the  284  residues  typical  of muscle 
tropomyosins,  to  248  residues  (or  247  after  processing 
[Cote,  1983]) which are the most abundant  in non-muscle 
cells.  The various tropomyosins  in  non-muscle  cells  have 
different actin-binding  activities, vary in their expression be- 
tween tissues,  and show different intracellular  localizations 
(Lin  et al,  1985;  Matsumara  and  Yamashiro-Matsumara, 
1985; Broschat and  Burgess,  1986;  Lin et al.,  1988; Pit- 
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tenger  and  Helfman,  1992).  Transformation  by oncogenic 
viruses  affects  isoform  expression  at  the  transcriptional 
level, with the longer isoforms being reduced in favor of in- 
creased expression of the shorter forms. These changes ac- 
company  alterations  in  cell  morphology  (Hendricks  and 
Weintraub,  1981; Matsumara et al,  1983; Lin et al.,  1985; 
Cooper  et  al.,  1985).  Despite  the  clear  importance  of 
tropomyosins,  the distinct  contributions  of the various  iso- 
forms have been difficult to ascertain. 
The budding yeast Saccharomyces cerevisiae has become 
a popular organism for studying basic cellular processes, in- 
cluding those involving the F-actin cytoskeleton. In spite of 
its small genome size and evolutionary  distance from mul- 
ticellular eukaryotic cells, the similarity in the functional or- 
ganization  of the  microfilament  based cytoskeleton from 
yeast to man is remarkable (for review see Bretscher et al, 
1994; Welch et al.,  1994). In yeast, actin shows a cell cy- 
cle-regulated distribution  that implies a role in the delivery 
of materials  to the cell surface for polarized growth.  Actin 
filaments are found in two distinct locations:  bundles of fila- 
ments ("cables") extend from the mother into the bud, and 
actin filaments are associated with cortical structures that are 
likely to be the sites of cell surface growth.  Many compo- 
nents  of the  yeast microfilament  cytoskeleton have  been 
identified and the consequences of loss of these components 
explored.  One of these components  is tropomyosin. 
The major form of tropomyosin  in budding  yeast is the 
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acterization revealed that Tpmlp has many features in com- 
mon with higher cell tropomyosins, including heat stability, 
acidic isoelectric point,  and cooperative,  saturable cation- 
dependent binding to F-actin (Liu and Bretscher,  1989a). 
The predicted product of the TPM/gene is 199 residues in 
length, has sequence characteristics of a coiled-coil protein 
and shows 20%  identity to higher cell tropomyosins. Im- 
munolocalization reveals that Tpmlp selectively associates 
with actin cables in yeast, but is not enriched in the cortical 
patches that are probably the sites of  cell surface growth (Liu 
and  Bretscher, 1989b, Mulholland  eta  l,  1994). Loss  of 
Tpmlp results in viable, but unhealthy cells, which lack actin 
cables, suggesting that Tpmlp is important for the stability 
of actin  cables,  and  randomized  cortical  structures.  Two 
lines of evidence suggest that Tpmlp is important for polar- 
ized transport of vesicular material for cell surface growth 
in yeast. First, phenotypic analysis of  cells lacking Tpmlp re- 
veals partial defects in polarized delivery to the cell surface, 
in mating projection formation, in cell fusion during mating, 
and the  abnormal  accumulation  of intraceUular vesicles. 
Second, genetic data  indicate that Tpmlp and the double- 
headed non-filamentous myosin encoded by MY02 function 
in the same pathway, which in the case of Myo2p has also 
been suggested to be in vesicular transport (Johnston et al., 
1991).  Additional genetic  data involving combinations  of 
conditional mutations in SEC genes with tpmlA suggest that 
the vesicular accumulation phenotype of strains harboring 
tpmlA is  due to a  post-Golgi  defect (Liu and  Bretscher, 
1992). 
Here  we  describe  the  presence  of a  gene,  designated 
TPM2, that encodes a second tropomyosin in yeast. Charac- 
terization of the purified Tpm2p and analysis of disruptions 
of  the TPM2  gene indicate that it performs a distinct function 
from Tpmlp, but that together TPM1 and TPM2  perform an 
essential function. 
Materials and Methods 
Plasmid and Strain Construction 
All PCR products were initially recovered using the TA cloning kit (Invitro- 
gen, San Diego, CA). The strain DH5~ was used for all manipulations in- 
volving Escherichia coli. The lithium acetate method was used for all yeast 
transformations (Ito et al.,  1983).  The S.  cerevisiae  strains used in this 
study are listed in Table I. 
Construction of  pBDlO0: GALl-TPM1 
Overexpression Plasmid 
The Tpmlp overexpression plasmid previously described (Liu and Bret- 
scher,  1989b)  contains the GALIO-GALI promoter region and the TPM1 
gene including 219  bases of upstream coding region. In this construct, 
Tpmlp is not under tight transcriptional control of the GAL/promoter. A 
construct which allowed controlled expression of  Tpmlp was created by exo- 
nuclease Ill treatment of this plasmid to remove bases -171 to -18 of the 
TPM/ upstream flanking region. When this plasmid (pBD100)  was intro- 
duced into a tpm/A strain and grown on minimal media containing glucose, 
no detectable Tpmlp was produced and there was no suppression of the 
tpm/A-associated defects. 
Construction of  pBDlOl: GAL1-TPM2 
Overexpression Plasmid 
The GALIO-GAL1 promoter region from YCpS0-Sc4816AAUG  (Goff et al., 
1984)  was  cloned  into  the  EcoRI-BamHI  sites  of 2  #t-based  plasmid 
YEp352,  as described in a  previous paper (Hill  et al.,  1986;  Liu and 
Bretscher, 1989b). The TPM2 gene was amplified using PCR, using primers 
which introduced a Sail site -4-bases upstream of the start codon and a 
HindlH site 46g-bases downstream of the stop codon. PCR amplification 
using genomic DNA from the wild type diploid ABYI73 as template pro- 
duced a fragment of about 970 bases. This was cloned into the Sall-HindlII 
sites behind the GAL/promoter to generate plasmid pBDI01. The authentic- 
ity of TPM2 was confirmed by DNA sequence analysis. 
Construction of  pBDl03: a Vector 
for tpm2A:  :HIS3 Disruption 
Genomic DNA prepared from the wild type diploid strain ABY173 was 
used as the template for PCR amplification. The TPM2 gene (486-bp open 
reading frame) was amplified using a primer with homology to the 5' flank- 
ing sequence which had been engineered to insert a BamHI site 242-bases 
upstream of the start codon and a primer with homology to the 3' flanking 
sequence which introduced a HindllI site 482-bases downstream from the 
stop codon. PCR amplification produced a product of about 1.2 kb. The 
1.2-kb BamHI-HindIll fragment was cloned into pUC13. A  1.8-kb frag- 
ment containing the HIS3 marker was inserted into the TPM2 gene at the 
unique BgllI site at position 232 in the open reading frame. EcoRI digestion 
produces a fragment which contains the intervening HIS3 marker, flanked 
by 381 bases of 5' flanking sequence and TPM2 NH2-terminal coding re- 
gion on one side, and by 183 bases of TPM2 COOH-terminal coding region 
on the other.  The linear DNA  was transformed into wildtype diploids 
(ABY173)  and  His  +  transformants  were  isolated.  The  diploids  were 
sporulated and gave rise to four viable spores. His  + haploids did not con- 
tain detectable Tpm2p and therefore contained a disrupted TPM2 gene. 
Construction of  pBDl04: A Vector 
for tpm2A:  :  URA3 Disruption 
PCR amplification was used to obtain a 229-bp fragment of 5' flanking se- 
quence using primers which insert a BamHI site at position -232 and a SalI 
site at position -23 upstream from the TPM2 start codon. This fragment 
was cloned into the BamHI-SalI sites in the Ylp5 plasmid. A EcoRI-HindllI 
fragment containing 71 bases of TPM2 COOH-terminal coding region and 
482 bases of 3' flanking region was cloned into the same construct. Diges- 
tion of this plasmid with BamHI and HindIII produces a linear DNA which 
contains 229 bases of TPM2 5' sequence. Ylp5 plasmid DNA containing 
the URA3 selectable marker, and 553 bases including part of the COOH- 
terminal coding region and 3' flanking sequence. The linear DNA was intro- 
duced into a  wild type haploid strain and Ura  + transformants were iso- 
lated. Alternatively, the plasmid was introduced into the diploid (ABY173) 
which was then sporulated.  Four viable spores were recovered, two of 
which were Ura  + and lacked detectable Tpm2p. 
Purification of ~m2p 
Cells  (ABY432),  lacking  Tpmlp and  carrying the GALI-TPM2 plasmid 
pBD101, were grown to early log phase in minimal media with galactose. 
The cells were harvested, washed, resuspended in extraction buffer (0.3 M 
KCI,  0.5  mM  MgCL2,  50  mM  Imidazole/HCl,  pH  6.9,  0.3  mM 
phenylmethylsulfonyl fluoride),  and lysed by passage through a  French 
press at 15,000 p.s.i. Cell lysate was boiled for 10-20 rain and then cen- 
trifuged at 12,000 g for 20 min to allow recovery of heat stable, soluble pro- 
teins. Ammonium sulfate was added to the supernatant to give 40% satura- 
tion and then centrifuged to remove the precipitate. The ammonium sulfate 
concentration was increased to 80 % saturation and the precipitated material 
recovered by centrifugation at 12,000 g for 20 min. The resulting pellet was 
resuspended in a minimal volume, and dialyzed into 0.2 M KCI, 10 mM 
KH2PO4-K2HPO4, pH 7.0, 1 mM DTT. The material was clarified by cen- 
trifugation and applied to a 10 ml Q-Sepharose anion exchange column. The 
column was washed with 50 ml of buffer,  and then developed with a  100 
ml gradient from 0.2 to 1 M KCI. Peak fractions of the 25-kD heat stable 
protein eluted at about 0.4 M KCI. Fractions containing pure "l~m2p were 
obtained in this manner. These fractions were dialyzed into distilled water, 
and aliquots were frozen and lyophilized to allow preparation of concen- 
trated stock solutions. Approximately 2.8 mg of Tpm2p was obtained from 
a starting weight of 10 g wet, washed cells. 
Estimation of the Relative Abundance of ~mlp 
and Tpm2p 
To estimate the relative abundance of each tropomyosin, an enriched heat 
The Journal of Cell Biology, Volume 128, 1995  384 Table I.  Yeast Strains  Used in This Study 
Strain  Genotype*  Source 


















MATa, ura3-52,  his3-A200,  leu2-3,112,  lys2-801,  trpl-l (am) 
MATa,  GAL  ÷, ura3-52,  his3-A200,  leu2-3,112 
MATa,  GALL  ura3-52,  his3-A200,  1eu2-3,112, lys2-801,  ade2-101 
MATa,  1eu2-3,112; ura3-52,  abplA::URA3 
Matc~, ura3-52,  his3-A200,  1eu2-3,112, trpl-l(am), sac6A::URA3 
Mata,  leu2-3,112,  ura3-52,  his3A200,  ade2-101,  trpl-l (am), myo2-66 
CUY25  ×  CUY28 
MATa,  GAL  +, ura3-52,  his3-A200,  leu2-3,112;  lys2-801,  ade2-101,  tpml A::LEU2 
Mata, ura3-52,  his3-A200,  leu2-3,112,  ade2-101,  trp  l-l (am), myo  l A :  :LEU2 
CUY30 background, MATa  (YCp50-HO plasmid mediated mating type switch, Russell et ai., 
1986),  tpmlA::LEU2. 
Match, leu2-3,112,  ura3-52,  his3A200,  rays2-801, trpl-l (am), myo4A::URA3 
CUY29  [pBD101] 
ABY230  [pBDI01] 
CUY29  [pBD100] 
CU29  [pBDI00,  pBD102] 
ABY173,  tpm2A::HlS3/ + 
ABY 435 segregant, MATa,  ura3-52,  his3-A200,  1eu2-3,112, lys2-801,  ade2-101,  trpl-l (am), 
T.  Huffaker (Cornell University, 
Ithaca NY) 
T.  Huffaker 
T.  Huffaker 
T.  Huffaker 
Drubin et al.,  1988 
Adams et al.,  1991 
Johnston et al.,  1991 
Liu and Bretscher,  1989b 
Watts et al.,  1987 
This study 






tpm2A::HIS3  This study 
ABY439  ABY435  segregant, MATch, ura3-52,  his3-A200,  leu2-3,112,  lys2-801,  tpm2A::H1S3  This study 
ABY440  ABY435  segregant, MATch, ura3-52,  his3-A200,  1eu2-3,112, lys2-801  This study 
ABY441  CUY29,  tpm2A::URA3  This study 
ABY442  ABYI67  ×  ABY436  This study 
ABY443  ABY173,  tpm2A::URA3/+  This study 
* The presence of multicopy plasmids is indicated in square brackets,  whose construction  is described in Materials  and Methods. 
stable lysate of wild type cells was prepared and the abundance of the iso- 
forms determined by densitometry of Coomassie blue-stained SDS gels. 
Wild type diploid (ABY173) was grown to late exponential phase in rich 
medium,  harvested,  washed and  resuspended  in  extraction buffer  (see 
above).  50 g of cells were lysed by passage through a French press and 
boiled. The heat stable soluble fraction was dialyzed against 0.1 M KC1 in 
the same buffer and loaded on a 10 rnl Q-Sepharose column. After washing 
with the same buffer,  bound proteins were eluted with 1 M KCI. This en- 
riched fraction contains all the Tpmlp and Tpm2p and removes some other 
species that comigrate with these proteins in total heat stable lysates. The 
identity of the Tpmlp and Tpm2p polypeptides was determined in heat sta- 
ble lysates of strains lacking these proteins. 
Biochemical and Physical Characterization of Tpm2p 
Oxidative cross-linking of Tpm2p was performed as described (Stewart, 
1975).  Stokes radius values for Tpmlp and Tpm2p were determined using 
a Sepharose S-300 gel filtration column calibrated with BSA, ovalbumin, 
aldolase, and myoglobin. The sedimentation coefficient of Tpm2p was de- 
termined by sucrose gradient ultracentrifugation with BSA, ovalbumin, and 
myoglobin standards (Bretscher,  1984).  Matrix-assisted laser desorption 
mass spectroscopy of Tpm2p was performed on HPLC-purified Tpm2p as 
described (Wang and Chait,  1994). 
F-Actin Cosedimentation Assays 
Cosedimentation  assays  were  performed  using  rabbit  skeletal  muscle 
F-actin (Bretscher, 1984) and purified Tpmlp or Tpm2p. All proteins were 
dialyzed into 100 mM KCI, 0.5  mM MgC12,  1 mM DTT,  2 mM ATE 5 
mM Tris-HCl, pH 7.6. For determination of Mg  2+ and KCI effects on bind- 
ing, 2 #M actin and 1.3 #M dimeric Tpm2p were used in each binding reac- 
tion.  Saturation binding of Tpmlp and Tpm2p to F-actin was carried out 
using increasing concentrations of either Tpmlp or Tpm2p and F-actin, at 
10 mM MgCl2  and 30 mM KCI.  To determine the effects of Tpmlp and 
Tpm2p on each others' binding behavior, assays were performed using sub- 
saturating ratios of tropomyosin to F-actin (2 #M actin, 0.4 #M Tpmlp, 0.5 
#M Tpm2p), with addition of increasing amounts of the other tropomyosin. 
100-#1 samples were mixed in micro-ultracentrifuge tubes for 30 min at 
room temperature, and then centrifuged at 125,000 g for 20 rain in a Beck- 
man TL100 ultracentrifuge to pellet F-actin and associated protein. Pellet 
and supernatant fractions were analyzed by SDS-PAGE and the ratio of 
tropomyosin bound to F-actin in the pellet fraction was determined by den- 
sitometry of Coomassie-stained gels. 
Genetic Techniques 
The  effect  of combining  tpm2A::HlS3  with  mutations  in  other  yeast 
cytoskeletal genes (abpl  A: : URA3, sac6A:  :  URA3 myol  A: :LEU2, myo2-66, 
myo4A::LEU2, tpmlA::LEU2) was determined by setting up crosses to pro- 
duce diploids heterozygous for both mutant alleles. These were sporulated 
and dissected, and segregation of marker genes, or, in the case of myo2-66, 
temperature sensitivity, was used for analysis of the products of each cross. 
In each cross, except between tpm/A and tpm2A, approximately equal num- 
bers of viable parental and non-parental ditypes were recovered. A plasmid 
loss experiment was used to confirm the synthetic lethality produced by the 
combination of tpm2A::HIS3 and tpmlA::LEU2 alleles by introducing ei- 
ther the GALI-TPM1 or GALI-TPM2 multicopy plasmids (pBD100, pBDI01) 
into the heterozygous diploid strain ABY442, which was sporulated and dis- 
sected. Leu  +,  His  +,  Ura  ÷ haploid isolates were recovered and tested for 
their ability to grow on 5-fluoroorotic acid (5-FOA)  I to determine if they 
could grow in the absence of the URA3-containing plasmid. Haploids which 
carried both the LEU2 and HIS3 markers, indicating that both TPMI and 
TPM2 genes were disrupted, were unable to grown on 5-FOA. 
l~m2p Over-expression Studies and 
Fluorescence Techniques 
The GALI-TPM2 multicopy plasmid (pBD101) was introduced into wild type 
and tpmlA.:LEU2 cells to generate strains ABY431 and ABY432.  Transfor- 
mants were grown in minimal media plus galactose to determine the effect 
of Tpm2p over-expression. Cultures were grown to early log phase and fixed 
1. Abbreviation used in this paper: 5-FOA, 5-fluoroorotic acid. 
Drees et al.  TPM2 in Yeast  385 in 3.7% formaldehyde  for 1 h at room temperature. Cells were washed, 
resuspended at a e.oncentration  of 2 × 108 cells/ml, and incubated  at 4°C 
in PBS containing  20 U/ml rhodamine-phalloidin  (Molecular  Probes, Inc., 
Eugene, OR) to allow visualization  of the F-aetin cytoskeleton  by fluores- 
cence microscopy.  Chitinous bud scars were visualized by staining with 
Calcofluor (Fluorescent  Brightener  28; Sigma Chemical Co., St. Louis, 
MO) at a concentration  of 0.2 mg/ml. Cells were examined  in a Zeiss Ax- 
ioskop fluorescence  microscope  equipped for Nomarski and epifluores- 
cence. Images were recorded  on T-MAX 400 film. 
Immunological Techniques 
Rabbit polyclonal  antisera  was raised against  purified  Tpm2p,  The crude  an- 
tisera showed  significant  cross-reactivity  with "l~mlp. 
Results 
TPM2 Encodes a Protein with Homology to the 
TPM1 Gene Product and the Sequence Characteristics 
of  a Tropomyosin 
Sequencing of yeast chromosome IX revealed an open read- 
ing frame which encodes a protein with significant sequence 
homology to the TPM/gene product. As this is the second 
tropomyosin gene to be discovered in S. cerevisiae, we have 
designated it TPM2. 
The TPM2 gene encodes a  161-residue protein (Fig.  1) 
whose sequence contains  seven amino  acid heptad pseu- 
dorepeats typically having hydrophobic residues at the first 
and fourth position in each repeat, a feature characteristic of 
an or-helical  coiled-coil dimer (Stone and Smillie,  1978). 
When the sequences of the T/M/and TPM2 gene products 
are aligned they show 64.5 % overall sequence identity. A 
unique feature of the 199-residue TPM1 gene product is the 
presence of two  38-amino  acid pseudorepeating regions, 
found in residues 31-69 and 70-108, which show about 85 % 
sequence identity. When TPM/and  TPM2 are aligned for 
maximum  homology,  the  NH~  and  COOH  termini  show 
perfect alignment with an internal deletion in TPM2 that pre- 
cisely  coincides  with  one of the  pseudorepeats  in  TPM/ 
(Fig.  1). 
Expression and Purification of l]am2p 
Primers with homologies in the 5' and 3' flanking regions of 
the gene were generated and used to clone the TPM2 gene 
by PCR amplification from genomic DNA.  Sequencing of 
the cloned PCR product verified that it was the correct TPM2 
sequence. 
In order to allow high-yield production of Tprn2p protein 
for easier purification, TPM2 was placed under the control 
of  the GAL/promoter (Fig. 2A). The GAL1-TPM2 fusion was 
constructed on a multicopy plasmid and introduced into a 
tpmlA::LEU2 haploid yeast strain. Cells were grown in min- 
imal media in glucose, or in galactose to induce high-level 
expression of Tprn2p. Since all known tropomyosins remain 
soluble in crude cell extracts after the bulk of the proteins 
have been precipitated by heating to 95°C, the heat-soluble 
proteins in these cells were examined after growth in glucose 
or in galactose. Gel electrophoresis revealed a heat stable 
protein with an apparent molecular mass of  25 kD in the ceils 
grown in galactose but not in glucose (Fig. 2 B). 
Purification of the 25-kD protein was carried out using a 
tpmlA::LEU2  haploid strain carrying the GALI-TPM2 con- 
struct on a multicopy plasmid to eliminate the co-purifica- 
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Figure 1. Alignment of the TPM1 and TPM2  gene products. When 
the two sequences are aligned for maximal homology, they are 
64.5%  identical. Tpm2p Iacks one of the two amino acid pseu- 
dorepeating regions found in Tpmlp, which are indicated by sets 
of arrows. The TPM2  sequence is available from Genbank/EMBL/ 
DDBJ under accession number Z38059. 
don of Tpmlp. It was purified using a variation of the protocol 
developed for Tpmlp purification, which itself is based on 
typical methods for the isolation of nonmuscle tropomyosins 
(Cote and Smillie, 1981a; Liu and Bretscher, 1989a). In out- 
line, a heat stable, soluble cell lysate was prepared from cells 
grown in minimal media with galactose. This was fraction- 
ated by ammonium sulfate precipitation and Q-Sepharose 
anion exchange column chromatography. A  homogeneous 
preparation of Tpm2p was obtained (Fig. 2 B, lane 3). 
Biochemical and Physical Properties of l~m2p 
Biochemical and physical properties of Tpm2p were deter- 
mined,  and are compared to those of Tpmlp and platelet 
tropomyosin in Table II. The molecular mass of monomeric 
Tpm2p was determined by mass spectroscopy and found to 
be  19,115 D,  which  is  within  experimental  error of the 
predicted value of 19,127 D.  Like other tropomyosins, the 
25-kD apparent molecular weight of Tpm2p determined by 
gel electrophoresis is higher than that predicted by the amino 
acid sequence of the protein. 
Tropomyosins exist as dimers of two parallel a-helices in 
coiled-coil chains. Catalyzed air oxidation of cysteine resi- 
dues has been used to show that the two polypeptide chains 
in the dimer are in register (Stewart, 1975). Tpm2p contains 
a  single cysteine residue at position  137 in the amino acid 
sequence and air oxidation generated the expected dimeric 
Figure 2. (A) GALI-TPM2  ex- 
pression construct. This con- 
struct  was  made  in  a  mul- 
ticopy plasmid (pBDIO1) and 
introduced into tpm/A (ABY- 
432) cells. (B) Expression and 
purification  of Tpm2p. Lane 1, 
SDS-PAGE of heat stable sol- 
uble protein from cells grown 
in glucose; lane 2, cells grown 
in galactose; lane 3, Q-Sepha- 
rose peak fraction containing 
pure Tpm2p. 
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Tropomyosins with Equine Platelet Tropomyosin 
Tpmlp*  Tpm2p  Platelet  TMI[ 
Apparent subunit tool  wt  33  kD  25  kD§  30 kD 
Isoelectric  point  4.5  4.4¢  4.3 
Sedimentation coefficient  2.6 S  2.4 St  2.7 S 
Stokes radius  5.7 nm  5.2 nml  NR 
* Liu and Bretseher,  1989a. 
¢ Cote and SmiUie,  1981a. 
§ Apparent subunit molecular weight determined by SDS-PAGE. 
II Isoelectric  point of Tpm2p calculated from predicted protein sequence. 
'I Sedimentation coefficient  and Stokes radius determined as described. 
NR, not reported. 
species  as  determined by  gel  electrophoresis under  non- 
reducing conditions (not shown). Therefore, Tprn2p proba- 
bly exists as a dimer with the chains in register, as expected. 
Further characterization of Tpm2p included the determi- 
nation of its apparent Stokes radius (5.2 nm) by gel filtration 
and sedimentation coefficient  (2.4 S) in sucrose velocity gra- 
dients.  The isoelectric point predicted for the protein en- 
coded by the TPM2  open reading frame is 4.4, a value typical 
for tropomyosins. These values are all consistent with the 
Tpm2p being an elongated coiled-coil dimeric protein. 
Characterization  of the Interaction of Tpm2p 
with F-actin 
A  defining  characteristic of tropomyosins is  their cation- 
dependent  binding  to  F-actin.  To examine  the  ability  of 
Tpm2p to bind F-actin, cosedimentation assays with F-actin 
under various conditions were performed. Tpm2p exhibits 
Mg  2+  dependent F-actin binding,  with optimal binding  at 
>t2 mM MgC12 (Fig.  3 A).  This Mg  2÷ dependent binding 
profile is very similar to that obtained for Tpmlp and other 
nonmuscle tropomyosins (Cote and Smillie,  1981b; Fowler 
and Bennett, 1984; Matsumara and Yamashiro-Matsumara, 
1985; Liu and Bretscher,  1989a). 
The effect of ionic strength on the interaction of Tpm2p 
with F-actin was also determined using cosedimentation as- 
says performed in  10 mM MgC12 and at differing concen- 
trations of KC1 (Fig. 3 B). Tpm2p binding to actin was re- 
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Figure 3. Effect of Mg  2+  (,4) and KC1 (B) on "I~m2p interaction 
with F-actin. Binding was measured using F-actin cosedimentation 
assays. Results are expressed as molar ratio of  Tpm2p dimers to ac- 
tin monomers as determined by densitometry of stained SDS-PAGE 
of F-actin containing pellets. 
file quite distinct from that seen for Tpmlp. Tpmlp binding 
to  F-actin  is  nearly abolished at  300  mM  KC1  (Liu and 
Bretscher, 1989a), whereas under the same conditions an ap- 
preciable amount of Tpm2p can bind to F-actin. 
The ratio of  tropomyosin to F-actin at saturation was deter- 
mined for both Tpm2p and Tpmlp under conditions optimal 
for the binding of both tropomyosins (10 mM  MgC12, 30 
mM KCI). Ratios of tropomyosin bound to actin in the pellet 
fraction were determined by densitometry of stained gels, 
The molar ratio of Tpmlp dimers to actin monomers at satu- 
ration binding was 0.215, or approximately one Tpmlp dimer 
to 4.6 actin monomers. The molar ratio of Tpm2p dimers to 
actin monomers at saturation was 0.27, or approximately one 
Tpm2p dimer to 3.6 actin monomers. 
Tpmlp and Tpm2p Influence Each Other's Actin 
Binding Behavior In Vitro 
To determine if Tpmlp and  Tpm2p  could  influence each 
other's  F-actin  binding  behavior,  cosedimentation  assays 
were carried out using both proteins. In these experiments, 
the level of one protein was held constant, and increasing 
amounts of the other protein were added. All reactions were 
carried out at subsaturating ratios of tropomyosin to F-actin 
and at concentrations of 30 mM KC1 and  10 mM MgCI2. 
Addition of Tpmlp had little effect on the ability of Tprn2p 
to bind F-actin (Fig. 4 A). In contrast, addition of increasing 
levels of Tpm2p to reactions containing Tpmlp and F-actin 
showed that Tpm2p had a negative effect on Tpmlp binding 
to F-actin (Fig. 4 B). The molar ratio of Tpmlp bound to ac- 
tin decreased steadily as  Tpm2p was  added in increasing 
amounts.  Our results suggested that the binding of Tprn2p 
might be enhanced at low levels of Tpmlp (Fig. 4 A).  We 
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Figure 4.  Competition binding assays of Tpmlp and Tpm2p to 
F-actin. (A) Effect of increasing Tpmlp concentration on Tpm2p 
binding to F-actin. (B) Effect of increasing Tpm2p concentration 
on Tpmlp  binding to  F-actin. (C)  Amplification of the  slight 
cooperative effect which increasing Tpmlp has on Tpm2p binding 
to actin.  Results are  expressed as molar  ratios  of tropomyosin 
dimers  to  actin  monomers  as  determined  by  densitometry  of 
stained SDS-PAGE of F-aetin containing pellets. 
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initial ratio of Tpm2p to  F-actin in  order to amplify any 
cooperative effect on Tpm2p binding produced by addition 
of Tpmlp (Fig. 4 C). Under these conditions there was a re- 
producible small degree of  cooperativity, but it was not a ma- 
jor effect. Thus, under the conditions of our studies, Tpm2p 
competes with Tpmlp binding to F-actin, suggesting that its 
interaction with the actin filament is stronger. These results 
demonstrate that Tpmlp and Tpm2p are able to inhabit the 
same actin filament and to influence each other's actin bind- 
ing behavior in vitro. 
TPM2 Is a Not an Essential Gene 
A  1.2-kb fragment containing the TPM2 gene and its sur- 
rounding 5' and 3' flanking sequences was amplified by PCR 
from  genomic  DNA  using  primers  which  introduced  a 
BamHI site 252-bases upstream of  the start codon and a Hind- 
III site 482-bases downstream of  the stop codon. A construct 
for disruption of TPM2 was generated by insertion of the 
HIS3 cassette at the unique Bgll site at position 237 in the 
open reading frame of the gene (Fig. 5 A). This linear frag- 
ment was  introduced into a wild type diploid strain. 
His  + diploids were isolated, sporulated, and dissected to 
determine if disruption  of the  TPM2 gene produced any 
phenotypic effects.  Dissection produced four viable segre- 
gants, with the HIS3 marker segregating 2:2. Immunoblots 
using polyclonal antiserum raised against purified Tpm2p 
demonstrated that Tpm2p was absent in heat stable cell ly- 
sates prepared from haploid His  + segregants from this cross 
(Fig. 5 C), revealing that the gene disruption was successful 
and that TPM2 is not an essential gene. Cells carrying the 
tpm2A::HIS3 disruption were indistinguishable from wild 
type cells in their growth rate on solid and in liquid media 
at 30°C, in their morphology, in their budding pattern as de- 
termined by Calcofluor staining, in their actin cytoskeleton 
as determined after rhodamine-phalloidin staining, in their 
A 
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Figure 5.  Disruption  of TPM2. (A) tpm2A::HIS3 construct  in 
pBD103 vector. The HIS3  marker gene was inserted at the BglII site 
at position 232, disrupting the gene. (B) tpm2A::URA3 construct 
in pBD104 vector. Disruption with this construct deletes all but the 
last 68 bases of COOH-terminal coding region. (C) Immunoblot 
using polyclonal antiserum raised against Tpm2p, which cross- 
reacts  with  Tpmlp. Lane  1,  heat  stable  soluble proteins  from 
tpm2A::HIS3 haploids (ABY436); and lane 2, heat stable soluble 
proteins from wild type haploids (ABY440). 
osmotic sensitivity as judged by growth on YPD containing 
0.6 M  NaC1 or their mating efficiency. 
Since the tpm2A::H1S3 disruption still had 232 bases of 
intact NH2-terminal coding sequence, it was possible that a 
truncated version of the TPM2 gene product was being pro- 
duced and  was  sufficient to  mask  any phenotypic effects 
which might result from total loss of the gene product. To 
verify that this was not the case, a second construct was used 
to replace the entire gene with the URA3 marker. Disruption 
of the TPM2 gene using this construct deletes all but the last 
68 bases of TPM2 coding region (Fig. 5 B). This construct 
was successfully introduced into a wild type haploid (CU'Y29) 
or diploid (ABY173) strain. Ura  ÷ haploids, generated by di- 
rect transformation or after sporulation of the diploid, were 
found to lack Tpm2p by immunoblot analysis of the heat sta- 
ble cell lysates. These tpm2A:: URA3 deletions also failed to 
generate any obvious phenotype. 
With  the  availability  of strains  that  specifically lacked 
Tpmlp or Tpm2p, we were able to unambiguously identify 
the polypeptides in heat stable lysates that were the products 
of the TPM/and TPM2 genes. Densitometry of Coomassie 
blue-stained gels of enriched heat stable lysates of exponen- 
tially growing wild type cells indicated that Tpmlp is about 
six times more abundant that Tpm2p. 
Genetic Interaction of tpm2A with 
tpmlA and Mutations in Other Genes Encoding 
Cytoskeletal Proteins 
To explore whether the TPM2 gene product functions with 
other components of the cytoskeleton, the effect of combin- 
ing tpm2A::HIS3 with other cytoskeletal mutations was in- 
vestigated, tpm2A::HIS3 haploid strains of appropriate mat- 
ing  type  (ABY436  or  ABY439)  were  crossed  with 
sac6A: :  URA3, abpl A" :  URA3, myol  A" :LEU2, myo2-66, and 
myo4A::LEU2 haploids (Watts  et al.,  1987;  Drubin et ai., 
1988;  Adams et al.,  1991; Johnston et al.,  1991; Haarer et 
al.,  1994).  Diploids  were  isolated,  sporulated,  and  dis- 
sected. In each of these cases non-parental ditypes were re- 
covered, and four viable spores were obtained in each case, 
indicating that TPM2 does not show any synthetic lethal in- 
teraction with these genes. 
The tpm2A strain was also crossed to tpmlA strain for the 
same  type of analysis.  Diploids were sporulated and dis- 
sected.  Out of 19 tetrads dissected,  four parental ditypes, 
four non-parental ditypes and eleven tetratypes were recov- 
ered. All haploids isolated from this cross were viable except 
for those that carried both the LEU2 and HIS3 markers, indi- 
cating that the tpm2A/tpmlA  combination is lethal. Micro- 
scopic examination of plates on which spores from this cross 
had been dissected revealed small clusters of four to eight 
cells, indicating that the defect is not in sporulation, but in 
cell growth. The synthetic lethality produced by the combi- 
nation of tpm2A and tpmlA was  verified by showing that 
eleven haploid  double  mutants  analyzed all  required the 
presence of either the TPM1 or TPM2 gene on a plasmid for 
viability. This demonstrates that tropomyosins are required 
for some essential function in S. cerevisiae, although the loss 
of either gene product alone is tolerated. 
Tpm2p Over-expression Alters Haploid 
Budding Pattern 
To gain insight into the function of Tpm2p, the GALI-TPM2 
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cells.  Galactose-induced  over-expression  of Tpm2p  pro- 
duced  no  obvious  effects  on  the  actin  cytoskeleton (not 
shown),  but  did  affect cell  polarity  (Fig.  6).  Normally, 
haploid yeast cells exhibit an axial budding pattern, in which 
the new bud emerges adjacent to the chitinous bud scar left 
behind from the previous cell division. A bipolar pattern, in 
which bud emergence may occur adjacent to or at the oppo- 
site pole from the previous cell division, is typical of diploid 
cells (reviewed by Drubin, 1991; Madden et al., 1992).  Ap- 
proximately 40%  of haploid cells  overexpressing  Tpm2p 
showed a  shift from the axial budding pattern  typical of 
haploid yeast cells (Fig. 6 B) to a bipolar budding pattern 
(Fig.  6  C).  This effect was not seen when Tpmlp was ex- 
pressed to similar levels using a GAL/-TPM/fusion  on a mul- 
ticopy plasmid. In haploid cells overexpressing both Tpmlp 
and Tpm2p, the degree of bipolar budding seen is 11%. This 
suggests  that the effect on cell polarity seen in response to 
Tpm2p overexpression is a result of  an altered ratio of  Tpm2p 
and  Tpmlp,  in  which  Tpm2p  is  in  excess.  When  Tpmlp 
Figure 6.  Effect of Tpm2p over-expression on budding pattern. 
(Panel A) Percentage of cells showing axial and bipolar budding. 
(A) Wild type haploids (CUY29); (B) wild type diploids (ABY173); 
(C)  GAL/-TPM/ over-expression haploids (ABY433) grown in 
galactose;  (D)  GAL-TPM2 over-expression haploids grown  in 
galactose (ABY431); (E) haploids overexpressing both TPM/ and 
TPM2 grown in galactose (ABY434). Cells were grown to log 
phase, labeled with Calcofluor, and cells with three or more bud 
scars were scored for axial or bipolar budding. (Panel B) Chitin 
labeling of wild type haploids (CUY29); (panel C) chitin labeling 
of haploids over-expressing TPM2 (ABY431). Bar, 5 t~m. 
production is raised to similar levels, the effect on cell polar- 
ity is reduced. 
Over-expression of Tpm2p in tpml A Cells Does Not 
Restore Wild 73jpe Morphology 
Disruption of the TPM1 gene results in the disappearance of 
actin cables from the yeast cytoskeleton and random distri- 
bution of actin patches  throughout both the  mother  and 
daughter cells (Fig. 7 C). Cells are defective in growth, mat- 
ing projection formation, and cell fusion during mating. Chi- 
tin, which is normally limited to the septum which forms 
during budding, is often randomly deposited over the entire 
cell surface (Fig. 6 D). These problems are believed to be 
a result of a partial defect in the targeted delivery of compo- 
nents to the cell surface (Liu and Bretscher,  1992). 
Galactose-induced over-expression of Tpm2p in a tpm/A 
strain (as shown in Fig. 2) resulted in partial restoration of 
actin cables in some cells (Fig. 7 E). In most cases, however, 
cells still showed an altered morphology and randomly dis- 
tributed  actin  patches  in  both  mother  and  bud.  Over- 
expression of Tpra2p did not correct the defect in chitin lo- 
calization in the tpm/A strain, indicating that the cells are 
still defective in targeted delivery to the cell surface. (Fig. 
7 F). Since the level of expression of Tpm2p in these cells 
was significantly higher than the normal level of Tpmlp in 
wild type cells (not shown), these results demonstrate that 
Tpm2p cannot substitute functionally for Tpmlp, even when 
it is present at many times its normal level in the cell. Over- 
expression of't~amlp to about the same level in tpm/A cells, 
restores fully the wild type phenotype (Liu and Bretscher, 
1989b). These data indicate that Tpm2p cannot fully substi- 
tute for Tpmlp and is therefore functionally distinct. 
Discussion 
Vertebrates contain an amazing diversity of  tropomyosin iso- 
forms. They differ in expression level, tissue distribution, 
and intracellular localization as well as in their F-actin-bind- 
ing properties and in the proteins with which they interact. 
Two size classes of tropomyosins have been recognized in 
vertebrates. Muscle tropomyosins contain 284 residues and 
span seven actin subunits along the actin filament. Smaller 
tropomyosins, having 247  or 248  residues,  are the major 
forms  found  in  non-muscle  tissues  and  span  six  actin 
subunits in a filament. Within these size classes are isoforms 
that are  tailor-made  for  specific  functions.  For example, 
splicing of the rat B-tropomyosin transcript in striated mus- 
cle cells results in a 284-residue protein with a domain con- 
taining a troponin-binding site, whereas alternative splicing 
of the same transcript in fibroblasts results in a 284-residue 
tropomyosin precisely lacking this domain (Helfman et al., 
1986).  The  function of most vertebrate tropomyosin iso- 
forms  is  not  yet  known.  In  this  report  we  show  that 
tropomyosin diversity extends to the yeast S.  cerevisiae, in 
which two tropomyosin genes,  TPM1 and  TPM2,  encode 
proteins with distinct yet overlapping functions. 
The product of the TPM/gene is the major tropomyosin 
in yeast and associates with actin filaments in vitro and in 
vivo (Liu and Bretscher, 1989a, b). Although the Tpmlp pro- 
tein migrates in SDS gels with a mobility characteristic of 
the tropomyosins with 248 residues, analysis of the TPM/ 
gene reveals a protein product with 199 residues. The prod- 
Drees et al.  TPM2 in  Yeast  389 Figure 7. Actin (A, C, and E) and Chitin (B, D, and F) distribution  in CUY29 wild type haploids (A and B); ABY167 tpmlA haploids 
(C and D); and ABY432 tpmlA haploids overexpressing TPM2 and grown in galactose. Cells were grown to log phase, fixed, and treated 
with rhodamine-phalloidin  to label F-actin and Calcofluor to label chitin. All panels are printed at the same final magnification. Bar, 5 tzm. 
uct of the TPM2 gene described in this report is shorter still; 
it has only 161 residues. A diagram of the sequence relation- 
ships between the major classes of vertebrate tropomyosins 
with  the  yeast  proteins  is  shown  in  Fig.  8.  The  two  S. 
cerevisiae  proteins show about 20 % sequence identity to ver- 
tebrate tropomyosins, but are 64.5 % identical to each other. 
This relatedness is supported by our biochemical studies; as 
is the case for Tpmlp, biochemical characterization estab- 
lishes that Tpm2p is a tropomyosin with many features com- 
mon to tropomyosins in other organisms. The fission yeast 
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Figure 8.  Diagram of the se- 
quence relationships between 
vertebrate  and  yeast  tropo- 
myosins. The degree of over- 
all sequence identity of ver- 
tebrate tropomyosins  to "l~mlp 
is shown. Tpmlp has been di- 
Number of actin monomers  vided into four regions: A, B, 
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I  4  which is suggested by homol- 
161  ogy with Tpm2p. 
Schizosaccharomyces  pombe is another example of a primi- 
tive eukaryote which has at least two tropomyosin isoforms, 
a higher molecular weight protein which is immunologically 
related to Tpmlp (Liu and Bretscher, 1989a) and a lower mo- 
lecular weight form of identical size to Tpmlp, encoded by 
cdca, which is essential for cytokinesis (Balasubraminian et 
al.,  1992). 
Could there be additional tropomyosins in S.  cerevisiae? 
Tpmlp is clearly the major isoform, and the only other one 
we have detected is Tpm2p, which is present at about one 
sixth the abundance of Tpmlp. If there are additional iso- 
forms, they must be much less abundant than Tpm2p,  so the 
presence of additional forms cannot be completely excluded. 
Moreover, tropomyosins, present only at specific stages of 
the yeast life cycle, such as during mating or sporulation, 
would not have been identified in our studies. 
The 284-residue muscle tropomyosins make seven half- 
turns per molecule and span seven actin monomers as they 
lie in the grooves along either side of the actin filament 
(Philips et al.,  1986).  Each half-turn comprises approxi- 
mately 39 residues of the o~ helix, with additional residues 
at the ends of  the protein for head-to-tail overlap between ad- 
jacently bound tropomyosins. Disruption of the structural 
periodicity by removal of part of a half-turn disrupts actin- 
binding ability (Hitchcock-DeGregori and Varnell,  1990). 
The shorter 247- or 248-residue non-muscle tropomyosins 
span six actin monomers along the filament as determined 
biochemically and using this estimate of actin binding site 
size (Cote, 1983).  Assuming that Tpmlp and Tprn2p follow 
the  same  structural rules as vertebrate tropomyosins, the 
number of actin monomers that each protein is predicted to 
span is five and four, respectively (Fig. 8). Measurements of 
the ratio of tropomyosin bound to F-actin under saturating 
conditions show that the molar ratio of actin monomers to 
Tpmlp dimers is about 4.6, and of actin monomers to Tpm2p 
dimers 3.6. These values are in good agreement with the 
predicted values. 
Analysis of the Tpmlp sequence reveals that it has a 38 
amino acid pseudorepeat, with the two sequences being 85 % 
identical  (Fig.  8).  Tprn2p  precisely  lacks  one  of these 
repeats. Vertebrate tropomyosins do not show such obvious 
pseudorepeating regions; they must be a feature of primitive 
tropomyosins which was not conserved throughout evolu- 
tion. In light of the size of this repeat, and the number of ac- 
tins that Tpmlp and Tpm2p span along a filament, the repeat 
is strongly suggestive of an actin monomer binding site. 
We have used a number of approaches to try to elucidate 
the similarities and differences in properties and functions of 
Tpmlp and Tpm2p.  In vitro studies reveal that the profile of 
Mg2+-dependent binding of Tpm2p to F-actin is very simi- 
lar to that of "l~mlp and vertebrate non-muscle tropomyo- 
sins. As expected, binding of "l~rn2p to F-actin decreases 
with increasing ionic strength, but in a manner quite distinct 
from that seen with Tpmlp (Liu and Bretscher, 1989a).  The 
binding of Tpmlp to F-actin is very sensitive to the salt con- 
centration, being nearly abolished at 300 mM KCI. In con- 
trast, Tprn2p binding is reduced by less than 50 % at 400 mM 
KC1 under otherwise identical conditions. Under conditions 
optimal for binding of  both tropomyosins, Tpmlp and Tprn2p 
can influence each others' actin binding behavior, which es- 
tablishes that they can inhabit the same actin filament. Com- 
petition studies reveal that Tprn2p can compete with and de- 
crease Tpmlp's  binding to F-actin in vitro.  Since Tpm2p 
appears to have four F-actin-binding sites,  compared with 
Tpmlp's five, these four sites must bind F-actin with a higher 
affinity or there must be more head-to-tail interaction be- 
tween Tprn2p molecules to achieve this effect.  Since there 
appears to be sufficient Tpmlp protein in vivo to bind to all 
available  F-actin (Liu and Bretscher,  1989a),  it is not sur- 
prising that the much less abundant Tpm2p binds F-actin 
more tightly than Tpmlp, otherwise little of it would bind 
F-actin in vivo. 
Changes in tropomyosin expression accompany changes in 
morphology  in  cultured  cells  transformed  by  oncogenic 
viruses, such as SV-40 and the Rous sarcoma virus (Cooper 
et al., 1985; Lin et al., 1985).  Microfilament content of the 
major nonmuscle tropomyosins is decreased, while the con- 
tent of the minor isoforms increases. This altered balance of 
Drees et al.  TPM2 in  Yeast  391 tropomyosin expression is likely to be involved with or to be 
a direct cause of the cytoskeletal changes typical of trans- 
formed cells (Matsumara et al, 1983; Lin et al., 1985). We 
found that altering the relative expression levels  of Tpmlp 
and Tpm2p in yeast has an effect on cell polarity, specifically 
on bud site selection. Over-expression of Tpm2p, but not of 
Tpmlp,. resulted in a shift from axial to bipolar budding in 
haploid cells. Since this effect can be partially suppressed by 
over-expression of Tpmlp, the ratio of the two tropomyosins 
appears to be important for correct morphogenesis. Thus, 
inappropriate replacement of Tpmlp by Tpm2p alters mi- 
crofilament composition, which in turn alters determination 
of cell polarity. 
Disruption of TPM2 reveals that, like TPM/,  it is not an 
essential gene.  tpm/A  cells  are  sickly and have multiple 
defects in growth and targeting of components to the cell sur- 
face (Liu and Bretscher, 1989b,  1992); tpm2A cells have no 
detectable phenotype. Combination of these two disruptions 
results  in  lethality,  demonstrating  that  tropomyosins are 
required for some essential function in yeast. The two tro- 
pomyosins may act together in this function, or they may 
simply share enough structural and functional similarity to 
allow each one to compensate for the other's absence and 
thereby maintain viability. 
While genetic evidence indicates that "l~mlp and Tpm2p 
function together or cooperate in some way, in vitro studies 
show that the proteins are biochemically distinct. In addi- 
tion, TPM/interacts genetically with MY02 (Liu and Bret- 
scher, 1992), whereas TPM2 appears to have no such inter- 
action. The failure of Tpm2p overexpression to rescue the 
cytoskeletal or transport defects in the tpm/A mutant pro- 
vides in vivo evidence for functional differences. Therefore, 
while the two proteins are clearly able to participate in the 
performance of some essential cellular function, Tpmlp and 
Tpm2p are not functionally identical. We believe that each 
is involved in additional, distinct cellular processes. Iden- 
tification of those gene products which interact with both 
Tpmlp and Tpm2p and those which interact specifically with 
only one of them should illuminate the nature of their func- 
tional divergence. 
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